{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T10:31:28Z","timestamp":1767177088552,"version":"build-2238731810"},"reference-count":57,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":2097,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Academic Emergency Medicine"],"published-print":{"date-parts":[[2002,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Our understanding of the pathophysiology of unstable angina (UA) and non\u2014ST\u2010segment elevation (NSTE) myocardial infarction (MI) [commonly referred to as NSTE acute coronary syndrome(s) (ACS)] has evolved considerably over the years, with atherothrombosis playing a pivotal role. This review discusses the molecular interactions in coronary thrombosis that may serve as therapeutic targets for more effective management of these syndromes. The purposes of this review are: 1) to discuss current understanding of the pathophysiology of NSTE ACS; 2) to describe recent studies with novel antithrombotic agents [e.g., low\u2010molecular\u2010weight heparin, thienopyridines, glycoprotein (GP) IIb\u2010IIIa inhibitors] in patients with NSTE ACS; and 3) to highlight recommendations for management of patients with NSTE ACS in the recently updated American College of Cardiology (ACC)\/ American Heart Association (AHA) guidelines, including the appropriate use of antithrombotic therapies.<\/jats:p>","DOI":"10.1197\/aemj.9.10.1029","type":"journal-article","created":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T18:24:28Z","timestamp":1033496668000},"page":"1029-1044","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["<i>Bench to Bedside<\/i>\n                    : Pathophysiology of Acute Coronary Syndromes and Implications for Therapy"],"prefix":"10.1111","volume":"9","author":[{"suffix":"Jr.","given":"Gerard X.","family":"Brogan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07493-4"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1067\/mem.2000.105601"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.18327"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00136-2"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.18.1860"},{"key":"e_1_2_1_7_1","article-title":"A macro and micro view of coronary vascular insult in ischemic heart disease","volume":"82","author":"Davies MJ","year":"1990","journal-title":"Circulation."},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.93.7.1354"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.3.657"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)00381-0"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117619"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1991.tb43703.x"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506083322306"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.3.907.907"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(87)90233-9"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198710223171704"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.90.2.988"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960190506"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198308183090703"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198511283132201"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198810273191701"},{"key":"e_1_2_1_22_1","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)92336-G","article-title":"The RISC Group Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease","volume":"336","year":"1990","journal-title":"Lancet."},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.324.7329.71"},{"key":"e_1_2_1_24_1","unstructured":"Braunwald E Antman EM Beasley JW et alACC\/AHA guideline update for the management of patients with unstable angina and non\u2010ST\u2010segment elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina): American College of Cardiology and the American Heart Association 2002: Available at:http:www.acc.orgclinicalguidelinesunstableunstable.pdf."},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.88.5.2045"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.16.1849"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199708143370702"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.15.1593"},{"key":"e_1_2_1_29_1","article-title":"The NICE 3 Investigators. The use of enoxaparin and IIb\/IIIa antagonists in acute coronary syndromes, including PCI: final results of the NICE 3 study [abstract]","volume":"37","author":"Ferguson JJ","year":"2001","journal-title":"J Am Coll Cardiol."},{"key":"e_1_2_1_30_1","article-title":"Anti\u2010thrombotic combination using tirofiban and enoxaparin: the ACUTE II study [abstract]","volume":"102","author":"Cohen M","year":"2000","journal-title":"Circulation."},{"key":"e_1_2_1_31_1","volume-title":"The INTegrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndromes Treatment (INTERACT) trial","author":"Goodman SG","year":"2002"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.17.1680"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.90.4.1757"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)80345-2"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)00500-5"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.11.1085"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.17.3.528"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199448040-00007"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1161\/hc3301.094533"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199805213382103"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199805213382102"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808133390704"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)10172-0"},{"key":"e_1_2_1_44_1","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1182\/blood.V94.2.587","article-title":"Fibrinogen receptor antagonist\u2010induced thrombocytopenia in chimpanzee and rhesus monkey associated with preexisting drug\u2010dependent antibodies to platelet glycoprotein IIb\/IIIa","volume":"94","author":"Bednar B","year":"1999","journal-title":"Blood."},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)10452-9"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)05060-1"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)00321-5"},{"key":"e_1_2_1_48_1","doi-asserted-by":"crossref","DOI":"10.1002\/clc.4960221703","article-title":"Trials of glycoprotein IIb\u2010IIIa inhibitors in non\u2014ST\u2010segment elevation acute coronary syndromes: applicability to the practice of medicine in the United States","volume":"22","author":"Cohen M","year":"1999","journal-title":"Clin Cardiol."},{"key":"e_1_2_1_49_1","article-title":"Maintenance of clinical benefit at six\u2010months in patients treated with platelet glycoprotein IIb\/IIIa inhibitor eptifibatide versus placebo during an acute ischemic coronary event [abstract]","volume":"98","author":"Harrington RA","year":"1998","journal-title":"Circulation."},{"key":"e_1_2_1_50_1","doi-asserted-by":"crossref","DOI":"10.1002\/clc.4960230902","article-title":"Management of patients with non\u2014ST\u2010segment elevation acute coronary syndromes","volume":"23","author":"Fintel DJ","year":"2000","journal-title":"Clin Cardiol."},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.22.2892"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200106213442501"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.15.1667"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010746"},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05701-4"},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.17.10.1859"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/16.suppl_L.50"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(00)01426-0"}],"container-title":["Academic Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1197%2Faemj.9.10.1029","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1197\/aemj.9.10.1029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T09:45:33Z","timestamp":1700300733000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1197\/aemj.9.10.1029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":57,"aliases":["10.1111\/j.1553-2712.2002.tb02138.x"],"journal-issue":{"issue":"10","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["10.1197\/aemj.9.10.1029"],"URL":"https:\/\/doi.org\/10.1197\/aemj.9.10.1029","archive":["Portico"],"relation":{},"ISSN":["1069-6563","1553-2712"],"issn-type":[{"value":"1069-6563","type":"print"},{"value":"1553-2712","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10]]},"assertion":[{"value":"2008-06-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}